| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
vasoactive intestinal peptide | 0.437 | 0.846 | 4.2E-04 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
C-X3-C motif chemokine receptor 1 | 0.457 | 0.885 | 6.1E-02 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
urocortin | 0.539 | 0.769 | 0.45 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
nuclear factor kappa B subunit 2 | 0.509 | 0.808 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
solute carrier family 17 member 8 | 0.729 | 0.462 | 1.3E-03 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
FKBP prolyl isomerase 1A | 0.641 | 0.654 | 0.81 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
enolase 2 | 0.475 | 0.846 | 0.38 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
4-aminobutyrate aminotransferase | 0.628 | 0.538 | 6.3E-03 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
adenylate cyclase activating polypeptide 1 | 0.510 | 0.846 | 0.52 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
GDNF family receptor alpha 2 | 0.716 | 0.423 | 9.8E-02 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
NADH:ubiquinone oxidoreductase core subunit S3 | 0.581 | 0.769 | 5.8E-04 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
cytochrome c oxidase subunit I | 0.441 | 0.885 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
LYN proto-oncogene, Src family tyrosine kinase | 0.603 | 0.615 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 |